Literature DB >> 34741628

Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report.

Ting Liu1, Xinxin Cao2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34741628     DOI： 10.1007/s00277-021-04719-1

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  8 in total

1.  Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report.

Authors:  Maria Rubinstein; Amer Assal; Marina Scherba; Jordan Elman; Robert White; Amit Verma; Marianna Strakhan; Farnoush Mohammadi; Murali Janakiram
Journal:  Am J Hematol       Date:  2016-02       Impact factor: 10.047

2.  Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.

Authors:  Xiaodong Li; Yuxiao Hong; Qian An; John Chen; Huachen Wei; Hong-Duo Chen; Xing-Hua Gao
Journal:  JAMA Dermatol       Date:  2013-08       Impact factor: 10.282

Review 3.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity.

Authors:  E Foucar; J Rosai; R Dorfman
Journal:  Semin Diagn Pathol       Date:  1990-02       Impact factor: 3.464

4.  Rosai-Dorfman disease successfully treated with thalidomide: A case report.

Authors:  Mohammad Shahidi-Dadras; Behnaz Hamedani; Nasim Niknezhad; Nasim Ghilizadeh
Journal:  Dermatol Ther       Date:  2019-07-02       Impact factor: 2.851

Review 5.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

6.  Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.

Authors:  Gaurav Goyal; Aishwarya Ravindran; Jason R Young; Mithun V Shah; N Nora Bennani; Mrinal M Patnaik; Grzegorz S Nowakowski; Gita Thanarajasingam; Thomas M Habermann; Robert Vassallo; Taimur Sher; Sameer A Parikh; Karen L Rech; Ronald S Go
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

7.  Long-time remission of laryngeal Rosai-Dorfman disease with thalidomide: a report of three cases.

Authors:  Chong Wei; Dao-Bin Zhou
Journal:  Hematology       Date:  2021-12       Impact factor: 2.269

8.  Rosai-Dorfman disease with spontaneous resolution: case report of a child.

Authors:  Felipe Barbosa Lima; Pedro Samuel de Valões Barcelos; Ana Paula Nunes Constâncio; Cleto Dantas Nogueira; Antônio Aldo Melo-Filho
Journal:  Rev Bras Hematol Hemoter       Date:  2011
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.